Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Dose Escalation Study of AZD2171 in Japanese Patients with Solid Tumors
jRCT2080220419Phase 1
- Sponsor
- AstraZeneca
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cediranib in Nonhematologic neoplasms, sponsored by AstraZeneca.
02
Drugs
cediranib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080220419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220419.